News About: Pharm. Industry
Hanmi grew 33.4 percent in September
The value by Hanmi Pharm in the outpatient prescription sector in September grew 33.4 percent, to 18.7 billion won, compared with the same month of last year, due to strong demand of its first generic version of Norva...
Substantial changes foreseen in anti-hypertension drug markets.
Daewoong may introduce Olmetec, a new anti-hypertension drug, an angiotensin II receptor blocker, next year after its health registration completing in Oct. this year, which seems to cause a big change in the anti-hyp...
Amlodipine generics to curb monopoly growth of Norvasc.
The market shares of the Norvasc (anti-hypertension drug) and Amaryl (anti-diabetic drug) generic drugs grew up in a remarkable stance after the recent massive market entries.
A market survey conducted by UB Care ...
Pfizer Korea sponsors symposia on Detrusitol SR
Pfizer Korea said it has sponsored its launching symposium concerning Detrusitol (L-tolterodine tartrate) SR using a double-capsule DDS formulation, which is used to relieve urinary difficulties, including frequent ur...
SK pledged to be a global enterprise.
In the company workshop at the Telecommunication Public Servant Education Center located in Cheonan. Choongnam province from Oct. 6 to 7, President Shin Seung-kwon of SK Pharm. Co. declared the company vision ensuring...
Domestic erythropoietin market contested by 3 pharmaceutical firms
Business sources says that the domestic erythropoietin (EPO) market has emerged as an arena of tripartite competition CJ Corporation's Epokine, Choong-wae Pharm's Recormon (Roche licensing-in) and Daiichi-Kirin's Ara...
Competitors turn eyes to domestic anti-migraine market
Riding on a tidal wave of better public awareness on migraine, a number of new players are poised to enter the domestic market for gaining a bigger share, albeit its smaller annual market size valued at 7.0 billion wo...
Cialis wins 2004 Asian Brand Marketing Effectiveness Awards
Korea's public relations campaign for CIALIS (tadalafil), which has been shown to improve erectile function in most men, received a gold PR prize (Most Effective Use of Public Relations) in the 2004 Asian Brand Market...
Key products of foreign corporations on hot competition.
Most of foreign multinational drug corporations in Korea have enjoyed their business almost exclusively with their key R&D innovative products. However, recently these key products encountered a harsh competition and ...
Abbott Korea launches tulobuterol patch
Abbott Korea said it has launched tulobuterol patch (brandname: Hokunalin) for the treatment of asthma.
Tulobuterol patch, which was developed to address nocturnal symptoms and maintenance of lung function in asthm...
